2 news items
Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance
MRVI
23 Feb 24
analyst expectations. This stands out in an earnings cycle marked by conservative outlooks and below-consensus results.
The company’s
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
MRVI
22 Feb 24
, customers continuing to focus on capital conservation and heightened competition in certain areas
- Prev
- 1
- Next